Navigation Links
Large study reveals increased cancer risks associated with family history of the disease
Date:7/24/2013

A family history of cancer increases the risk of other members of the family developing not only the same cancer (known as a concordant cancer) but also a different (discordant) cancer, according to a large study of 23,000 people in Italy and Switzerland.

The research, published in the leading cancer journal Annals of Oncology [1] today (Thursday), provides a comprehensive picture of the risk of developing various different types of cancer in families where there is a history of the disease, and is one of the few large studies of this kind that takes into account other important factors, such as individual characteristics and lifestyles, that could affect the degree of risk as well.

Results from the study supported known associations, such as the increased risk of developing the same cancer as a close relative, and the 1.5-fold increased risk of breast cancer in women with a history of colorectal cancer in the family. However, the study also found a 3.3-fold increased risk of developing oral and pharyngeal cancer among people who had a first-degree relative with cancer of the larynx, and a four-fold increased risk of cancer of the gullet (oesophageal cancer) where a first-degree relative had oral or pharyngeal cancer. If a first-degree relative had breast cancer, female family members had a 2.3-fold increased risk of ovarian cancer. Family members had a 3.4-fold increased risk of prostate cancer if a first-degree relative had bladder cancer.

The researchers from Italy, Switzerland and France looked at 12,000 cases of cancer occurring in 13 different cancer sites (mouth and pharynx, nasopharynx, oesophagus, stomach, colorectum, liver, pancreas, larynx, breast, womb, ovaries, prostate and kidneys) between 1991 and 2009. They matched them with 11,000 people without cancer, and collected information on any cancer in the family, particularly in a first-degree relative, age at diagnosis, sociodemographic characteristics, body shape, lifestyle habits such as smoking and alcohol intake, diet, personal medical history, including menstrual and reproductive factors, and use of oral contraceptives and hormone replacement therapy.

Dr Eva Negri, head of the Laboratory of Epidemiologic Methods at the Mario Negri Institute for Pharmacological Research, Milan, Italy, said: "Besides confirming and quantifying the well-known excess risks of people developing the same cancer as their first-degree relative, we have identified increased risks for developing a number of different cancers. We have also found that if a patient was diagnosed with certain cancers when they were younger than 60, the risks of a discordant cancer developing in family members were greater.

"A major strength of our study is that we were able to adjust our analyses for tobacco, alcohol and a number of other lifestyle habits, which most previous studies have not been able to do."

Dr Negri said that some of the associations between discordant cancers were probably due to shared environmental factors such as family habits of smoking and drinking. However, she said: "Our results point to several potential cancer syndromes that appear among close relatives and that indicate the presence of genetic factors influencing multiple cancer sites. These findings may help researchers and clinicians to focus on the identification of additional genetic causes of selected cancers and on optimizing screening and diagnosis, particularly in people with a family history of cancer at a young age."

She said that the large numbers of patients in the study enabled the researchers to identify associations even for some rare cancers.

"For some rare cancers, a weak association with a different, common cancer can, on a population level, reveal a higher attributable risk than a strong association with the risk of developing the same cancer. For example, for ovarian cancer we found that a family history of breast cancer had a stronger attributable risk of ovarian cancer than the far rarer, albeit stronger, association with family history of ovarian cancer."

The researchers are still collecting data on the people they are studying, including biological material, which could help them to identify genetic factors that could be playing a role in the increased risk for people with a family history of cancer. They also plan to investigate whether some well-recognised risk factors are involved in increasing the risk to family members of developing concordant or discordant cancers, and if so, to what extent.


'/>"/>

Contact: Emma Mason
wordmason@mac.com
European Society for Medical Oncology
Source:Eurekalert

Related medicine news :

1. FlipOver.org Mobilizes Social Entrepreneurship Through Crowdsourcing Agreement with Indonesia’s Largest Youth Organization
2. Large UK population study finds no increased cancer risk in children born after assisted conception
3. UIC to serve as Chicago site for largest-ever US study of Hispanic/Latino health
4. Market Authority to Release White Paper That Provides Key Strategies for Large Directional Media/Print Companies
5. CyraCom Ranked Amongst the World’s Largest Language Services Providers
6. Smart ERP Solutions Moves Headquarters to New Larger Location
7. North America Leads the Largest Market Share of the Bioinformatics Market Says New Research Report by MarketsandMarkets
8. Challenge of Champions, the Largest Martial Arts Tournament of its Kind in the World, to be Held in Edison, New Jersey
9. Showers Positioned to Replace Bathtubs in Large Hotel Chains – On Trend with Bathroom Remodeling Industry
10. Deadly Super Bug Controlled in Large Study of Hospitals
11. Time and Gems Offers Buyers the Largest Collection of Rolex Watches Yet
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2017)... Boston, MA and Orlando, FL (PRWEB) , ... ... ... Strohbusch, Orbita PR Director, beth[at]orbitahealth[dot]com, +1 (414) 213-8818 , Orbita, Inc., a leading ... ™, a complete software-as-a-service solution for increasing patient engagement and optimizing care journey ...
(Date:2/20/2017)... Plano, Texas (PRWEB) , ... February 20, 2017 ... ... vital signs technology, welcomes you to stop by for a visit this week ... IT professionals, clinicians and executives from around the globe. Sensogram will be featured ...
(Date:2/20/2017)... (PRWEB) , ... February 20, 2017 , ... Chuck E. ... Sensory Sensitive Sundays, a joint event at Chuck E. Cheese’s locations throughout New England, ... other special needs, the opportunity to experience the fun of visiting Chuck E. Cheese’s ...
(Date:2/19/2017)... ... , ... ProBrand Glitch is a set of 30 glitch distortion logo reveals made exclusively for ... logo with a glitch reveal in just a few clicks of a mouse. Customizable glitch ... each preset. Use these presets to add a uniquely animated logo to any photos or ...
(Date:2/18/2017)... ... February 17, 2017 , ... Butler Mobility invited Ken ... Stairlift and other Butler products. Ken was impressed with the safety and reliability ... endorse the product on his show. This endorsement by Ken Matthews can be ...
Breaking Medicine News(10 mins):
(Date:2/20/2017)... LONDON , February 20, 2017 Acute, Chronic ... is expected to grow at a CAGR of 7% from 2016-2021 and ... a CAGR of 6% from 2016 to 2027. The market is estimated ... ... Read on to discover how you can exploit the future business ...
(Date:2/19/2017)... , February 18, 2017 ... agreement to purchase a Medical Delivery Service with the ... cannabis transactions between qualified patients and caregivers. The delivery ... , located in the Coachella Valley, California ... Greater Los Angeles area to the West, ...
(Date:2/18/2017)... , Feb. 17, 2017 Research and Markets ... Report" report to their offering. ... The report provides separate comprehensive analytics for the US, ... , Asia-Pacific , Latin America ... the period 2015 through 2022. Also, a six-year historic analysis is provided ...
Breaking Medicine Technology: